Cancer Immunology Research

Journal Title：Cancer Immunology Research

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

《癌癥免疫學研究》發表優秀的原創文章，報道癌癥免疫學的重大進展，涵蓋從宿主-腫瘤相互作用的基礎研究到模型系統中的發育治療、患者的早期轉化研究和后期臨床試驗。該期刊向癌癥研究界傳播免疫學知識，催化跨學科工作，從而加深對宿主-腫瘤關系的理解，更有效的癌癥治療方法和更好的臨床結果。

論文經過嚴格審查，具體主題包括內源性抗腫瘤免疫、促腫瘤炎癥、癌癥抗原、疫苗、抗體、細胞療法、細胞因子、免疫調節、免疫抑制、癌癥治療的免疫調節作用、新興技術和臨床研究。該期刊的特色包括“免疫學大師”——由頂尖免疫學家撰寫的入門書——和“癌癥免疫學的十字路口”——強調免疫學與其他癌癥研究領域和相關學科的交叉點的觀點。

Cancer Immunology Research創刊于2013年，由American Association for Cancer Research Inc.出版商出版，收稿方向涵蓋ONCOLOGY - IMMUNOLOGY全領域，在行業領域中學術影響力很大，屬于TOP期刊，國際一流期刊，關注度和專業度非常高，所以對原創文章要求創新性很高，過審難度很高，如果您有志于TOP期刊，建議關注此刊。平均審稿速度 ，影響因子指數8.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。